Korean J Med.
1999 Jan;56(1):18-24.
Meanings and Indications of pretreatment assessment of esophageal carcinoma with bronchoscopy
- Affiliations
-
- 1Department of Internal Medicine Yonsei University College of Medicine, Seoul, Korea.
- 2Department of Surgery Yonsei University College of Medicine, Seoul, Korea.
Abstract
OBJECTIVES
To determine the yield of bronchoscopy for evaluating tracheobronchial spread in
esophageal carcinoma and to identify the conditions for bronchoscopy in patients with newly
diagnosed esophageal carcinoma, who planned to be operated.
METHODS
From March 1989 to June 1997, 115 patients with esophageal carcinoma had received
bronchoscopy. Bronchoscopic findings were classified into three types: Type I: no definitive
endobronchial lesion, Type II: indirect effects(hyperemia and compression), Type III: invasion.
CT findings were classified into three classes: Class A: tumor separated from tracheobronchial
tree, Class B: abutting tree, Class C: compressing tree. We investigated the correlations of
clinical presentation and non-invasive tests (including esophagogram) with bronchoscopic findings.
RESULTS
1) Among 115 patients, bronchoscopic findings were Type I in 67(58.3%), Type II in 34(29.6%), Type III in 14(12.2%).
2) Abnormal bronchoscopic findings are related with length of lesion by esophagogram.(p < 0.05)
3) Class C lesion by chest CT scan were closely correlated with abnormal bronchoscopic findings.
4) Chest symptoms were frequently associated with type III lesion of bronchoscopy
CONCLUSION
We could recommend preoperative bronchoscopy in recently diagnosed as esophageal carcinoma who got more than 2 of 3 variables listed below: 1) patients who had chest symptoms, such as cough with sputum, hemoptysis, and dyspnea 2) length of tumor is long in esophagogram(above 5 cm in length), 3) tracheobronchial compressed lesion by chest CT scan.
Bronchoscopy is not needed in cases with no chest symptom, short lesion length(below 5 cm) and normal chest CT finding for preoperative evaluation of esophageal carcinoma.